Search results for: 'agentic AI Emerging Trends and Opportunities'
- Did you mean
- agentic ai emerging trends ad opportunities
- Related search terms
- Emerging Growth Opportunities within the APAC Internet of Things Market
- Trends and Growth Opportunities in the Feature On-demand (FoD) Business Models for Connected Services
- emerging market building management systems growth opportunities
- Emerging Software Providers for Smart Building and FM Markets, Global, 2026
- trends impacting the debondable adhesives market global 2020 2024
-
24 Feb 2015  |  Asia Pacific  |  Market Research
Analysis of the Global Oncology Drug Delivery Market
Future Impact of Emerging Technologies
The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...
$4,950.00 -
26 Sep 2011  |  Global  |  Technology Research
Radiation Oncology--Funding Trend Analysis (Technical Insights)
Radiation Oncology - Promising technologies providing a ray of hope for cancer.
This research service analyzes the funding scenario in radiation oncology industry sector and provides insights to investors for potential investments into promising technologies and offers strategic recommendations for firms for procuring funds. The study offers strategic analysis and insights on potential technologies worthy of investment and com...
$4,950.00 -
04 Jul 2016  |  North America  |  Market Research
The Global Immuno-oncology Therapeutics Market—Checkpoint Inhibitors
The Next Generation of Cancer Therapies
Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...
$8,000.00